Atlas Trials

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Clinical trial NCT00416455 · COMPLETED

Trial details

NCT number
NCT00416455
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell CarcinomaEndometrial Clear Cell CarcinomaEndometrial Papillary Serous CarcinomaStage I Endometrial CarcinomaStage IB Cervical CancerStage II Endometrial CarcinomaStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical Cancer
Start date
2007-09-01
Primary completion
2014-09-01
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.